Form 13-F position report

ALTO NEUROSCIENCE INC

Reported by MORGAN STANLEY

ANRO CUSIP 02157Q109 Manager CIK 0000895421

Reported 46,807 shares, down 155,834 (76.9%) from the prior quarter.

Reported value -88.2%; share count -76.9% vs. the prior quarter.

Reduced
% of reported 13F value < 0.01% This manager · Q1 2025
Shares 46,807 Quarter-end amount reported
Reported value $101,104 Fair value at quarter end
Consecutive quarters held 5 Through Q1 2025

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2024-03-31 203925
2024-06-30 281393
2024-09-30 871283
2024-12-31 857172
2025-03-31 101104
2025-06-30 142185
2025-09-30 245365
2025-12-31 1167343
2026-03-31 1543343
2026-06-30 1977666
2026-09-30 6663866

Quarterly position history

How this manager's reported quarter-end position changed over time.

11 quarters
Quarterly reported position history for ALTO NEUROSCIENCE INC held by MORGAN STANLEY.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Added 261,021 +186,081 (248.3%) < 0.01% $6,663,866 2026-11-13
Q2 2026 Added 74,940 +6,286 (9.2%) < 0.01% $1,977,666 2026-08-13
Q1 2026 Added 68,654 +3,073 (4.7%) < 0.01% $1,543,343 2026-05-15
Q4 2025 Added 65,581 +4,545 (7.4%) < 0.01% $1,167,343 2026-02-13
Q3 2025 Reduced 61,036 -3,594 (-5.6%) < 0.01% $245,365 2025-11-14
Q2 2025 Added 64,630 +17,823 (38.1%) < 0.01% $142,185 2025-08-15
Q1 2025 Reduced 46,807 -155,834 (-76.9%) < 0.01% $101,104 2025-05-15
Q4 2024 Added 202,641 +126,480 (166.1%) < 0.01% $857,172 2025-02-14
Q3 2024 Added 76,161 +49,838 (189.3%) < 0.01% $871,283 2024-11-14
Q2 2024 Added 26,323 +13,038 (98.1%) < 0.01% $281,393 2024-08-14
Q1 2024 New 13,285 +13,285 (0.0%) < 0.01% $203,925 2024-05-15

Who else reported the position

95 managers reported ALTO NEUROSCIENCE INC for Q1 2025.

Managers reporting ALTO NEUROSCIENCE INC in Q1 2025.
Manager Activity Shares Change % of reported 13F Reported value Tenure
Alpha Wave Global LP Unchanged 3,707,757 0 3.57% $8,008,755 5 qtrs
ARMISTICE CAPITAL LLC Added 1,600,000 +950,000 0.05% $3,456,000 2 qtrs
BlackRock Inc Reduced 1,459,176 -20,838 < 0.01% $3,151,820 3 qtrs
FMR LLC Added 1,272,686 +7,140 < 0.01% $2,749,002 5 qtrs
Point72 Asset Management L P Reduced 1,240,053 -452,100 < 0.01% $2,678,514 5 qtrs
VANGUARD GROUP INC Reduced 1,218,645 -11,022 < 0.01% $2,632,273 5 qtrs
FRANKLIN RESOURCES INC Unchanged 1,162,608 0 < 0.01% $2,511,233 5 qtrs
Vestal Point Capital LP Unchanged 915,000 0 0.14% $1,976,400 5 qtrs
AWM Investment Company Inc Added 901,984 +214,153 0.27% $1,948,285 5 qtrs
MARSHALL WACE LLP Added 852,990 +15,616 < 0.01% $1,842,457 2 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
March 31, 2025
Filed
May 15, 2025
Filing type
13F-HR
Position type
COM SHS

Voting authority reported

Sole
45,689
Shared
0
None
1,118

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.